EN DE
STOCK COMPARISON

Yunnan Hongxiang Yixintang vs Alibaba Health Information Technology: Fair Value & Quality

Both stocks run through our valuation models. Here is how Yunnan Hongxiang Yixintang (002727) and Alibaba Health Information Technology (0241) compare, as of Sep 24, 2026.

As of Sep 24, 2026, Fair Value Calculator sees Yunnan Hongxiang Yixintang as the less overvalued of the two: Yunnan Hongxiang Yixintang trades at ¥10.96 versus a fair value of ¥9.51 (-13%), while Alibaba Health Information Technology trades at HK$2.84 versus HK$2.03 (-28%).
Yunnan Hongxiang Yixintang
002727.SHE · CNY · Consumer Staples
-13%
upside to fair value
overvalued
Price¥10.96
Fair Value¥9.51
Quality65/100
Alibaba Health Information Technology
0241.HK · HKD · Health Care
-28%
upside to fair value
overvalued
PriceHK$2.84
Fair ValueHK$2.03
Quality64/100
Get comparisons like this free by email every month: the most undervalued quality stocks.

Head-to-head numbers

Green is the better side of a row, red the weaker one (for valuation multiples: lower = cheaper). Grey rows are for reference only and are not scored.

betterweakerfor reference, not scored

Yunnan Hongxiang YixintangAlibaba Health Information Technology
Valuation
22.8×P/E (TTM)22.0×
0.38×P/S (TTM)1.45×
0.88×P/B2.79×
6.3×EV/EBITDA30.4×
n/aPEG0.70×
−13.2%Fair value upside−28.4%
3.6%Dividend yieldn/a
¥0.40Dividend per sharen/a
Profitability
6%Operating margin2%
0.59×EBIT margin trend (5Y)n/a
4%Return on equity11%
2%Return on assets4%
Growth
-7%Revenue growth (YoY)8%
-0.2%Avg. growth/yr (3Y)8.6%
6.5%Avg. growth/yr (5Y)17.2%
−0.9%Value creation/yr+36.9%
Balance & size
5.6×Interest coverage (EBIT/interest)1,357.4×
$958MMarket cap$6B
mixedGrowth qualityhealthy
Valuation multiples (P/E, P/S, P/B, EV/EBITDA) are shown but not scored here: the two companies sit in different sectors, and multiples only compare fairly between similar business models. PEG stays scored, as it relates the P/E to growth.

Alibaba Health Information Technology leads: 2 to 6 metric wins.

n/a = not meaningfully computable, for example with negative equity.

Quality in detail

The quality score, broken down into the same factor families as on the stock page, 0 to 100 per family.

Yunnan Hongxiang Yixintangof which business quality 65 · market factors 38 Alibaba Health Information Technologyof which business quality 64 · market factors 13
ProfitabilityMargins and returns on capital today
44
60
Quality GrowthAre margins and returns improving?
45
56
CashflowEarnings quality: real cash, not paper profit
66
43
Fin. StrengthBalance sheet, leverage, solvency risk
62
97
InvestmentDisciplined investing over empire-building
100
85
Low VolatilityCalm price path (market factor)
76
26
MomentumPrice trend over the last 3–12 months (market factor)
26
12
52W MomentumDistance to the 52-week high (market factor)
16
0
Net IssuanceShare count: buybacks or dilution?
90
47

What the models say

How far the median fair value (base case) per model family sits from the current price, in percent. The amount in the currency of the trading venue is shown underneath.

above the price, more than 15% above close to the price, 85% to 115% of the price below the price, more than 15% below

Model familyYunnan Hongxiang YixintangPrice ¥10.96Alibaba Health Information TechnologyPrice HK$2.84
DCF Models+292%above the price¥42.97+4%close to the priceHK$2.94
Earnings-Based-7%close to the price¥10.23+48%above the priceHK$4.20
Dividend Discount-36%below the price¥6.98n/a
Multiples+36%above the price¥14.96-28%below the priceHK$2.03
Asset-Based-24%below the price¥8.36-74%below the priceHK$0.74
Growth DCF+273%above the price¥40.93-7%close to the priceHK$2.65
Economic Profit+10%close to the price¥12.04-58%below the priceHK$1.18
Growth Earnings-13%close to the price¥9.51+97%above the priceHK$5.58
Minimum-36%below the price¥6.98-74%below the priceHK$0.74
Maximum+292%above the price¥42.97+97%above the priceHK$5.58
Median+2%close to the price¥11.13-7%close to the priceHK$2.65
Geometric mean+31%above the price¥14.35-19%below the priceHK$2.28

Minimum, maximum, median and geometric mean refer to the family values in this table. Geometric because deviations are ratios: half the price and twice the price average to 100%, not 125%.

Yunnan Hongxiang Yixintang: 10 of 26 models see the stock below the current price.

Alibaba Health Information Technology: 15 of 24 models see the stock below the current price.

Scenario ranges

From our cautious bear scenario to the optimistic bull scenario. The white tick is the current price (value above it), the green tick the fair value (value below it): if the price sits left of the fair value, there is room to rise.

Yunnan Hongxiang Yixintang
Price ¥10.96
Fair Value ¥9.51
Bear ¥8.78Bull ¥12.36
Alibaba Health Information Technology
Price HK$2.84
Fair Value HK$2.03
Bear HK$1.36Bull HK$3.07

Compare two other stocks

Tap a field and type again, ticker or company name.

Free, no sign-up

Ranked within their sector

Where each stock sits within its sector peer group. Band = middle 50% of peers, tick = median, dot = this stock.

Yunnan Hongxiang Yixintang · Consumer Staples

Quality score65 · Top 25%
Fair value upside-13% · below median

Alibaba Health Information Technology · Health Care

Quality score64 · Top 25%
Fair value upside-28% · below median

Bottom line

As of Sep 24, 2026, Fair Value Calculator sees Yunnan Hongxiang Yixintang as the less overvalued of the two: Yunnan Hongxiang Yixintang trades at ¥10.96 versus a fair value of ¥9.51 (-13%), while Alibaba Health Information Technology trades at HK$2.84 versus HK$2.03 (-28%).

Yunnan Hongxiang Yixintang has the higher quality score (65/100).

Open Yunnan Hongxiang Yixintang live analysis →

More comparisons

Popular match-ups from the same sectors, all with fair value and quality score.

Free · Top-25 report

See the undervalued quality stocks every month

Just your email for the monthly Top-25 report of the most undervalued quality stocks, with fair value, quality and price target. Plus 14 days of Pro to try, no card.

Free. You confirm by email (double opt-in) and can unsubscribe anytime in one click. Not financial advice.

A model-based valuation snapshot from 26 models. Values change with price and fundamentals; the date shown above applies.